These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32621967)

  • 1. Dose investigation of imrecoxib in patients with renal insufficiency based on modelling and simulation.
    Li Y; Wang J; Huang J; Yu J; Wang Y; Tan H; Zhang H; Yang G; Pei Q
    Eur J Pharm Sci; 2020 Sep; 152():105449. PubMed ID: 32621967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of imrecoxib in patients with renal insufficiency.
    Pei Q; Xie JL; Huang J; Liu WY; Yang XY; Wang Y; Li W; Tan HY; Zhang H; Yang GP
    Eur J Clin Pharmacol; 2019 Oct; 75(10):1355-1360. PubMed ID: 31243478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects.
    Yang L; Shen Q; Hu C; Wang Y; Zhu X; Shu S; Luo Z
    Drug Des Devel Ther; 2022; 16():3865-3876. PubMed ID: 36388081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Fluconazole on the Pharmacokinetic Properties of Imrecoxib, a Novel NSAID: A Single-center, Open-label, Self-controlled Study in Healthy Chinese Male Volunteers.
    Zuo CZ; Gong Y; Hou XY; Zhang YF; Peng WX; Zhu RH; Zhong DF; Chen XY
    Clin Ther; 2018 Aug; 40(8):1347-1356. PubMed ID: 30017171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
    Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
    Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of imrecoxib and its two active metabolites in plasma of hepatic impairment patients by liquid chromatography-tandem mass spectrometry.
    Hou X; Dai X; Yang Y; Zhang Y; Zhong D; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1122-1123():58-63. PubMed ID: 31153132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and excretion of imrecoxib in rat.
    Xu H; Zhang Y; Sun Y; Zhang P; Chu F; Guo Z; Zhang H; Zhong D
    Xenobiotica; 2006 May; 36(5):441-55. PubMed ID: 16854781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients.
    Srinivas NR
    Eur J Clin Pharmacol; 2020 Mar; 76(3):469-471. PubMed ID: 31897535
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Liu Y; Zhang R; Li Z; Zhou J; Yang T; Yang C; Huang X; Zhang Y; Shi S
    Sci Rep; 2019 Oct; 9(1):15774. PubMed ID: 31673051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.
    Feng Z; Chu F; Guo Z; Sun P
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2270-2. PubMed ID: 19286379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate.
    Hou X; Zhou J; Yu S; Zhou L; Zhang Y; Zhong D; Chen X
    Drug Metab Dispos; 2018 Sep; 46(9):1320-1328. PubMed ID: 29980580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation on the hydroxylation metabolism of imrecoxib in vitro by using recombinant human CYPs].
    Li Q; Huang HH; Dong Y; Zhong DF
    Yao Xue Xue Bao; 2005 Oct; 40(10):912-5. PubMed ID: 16408808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
    Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
    Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes.
    Xu HY; Zhang P; Gong AS; Sun YM; Chu FM; Guo ZR; Zhong DF
    Acta Pharmacol Sin; 2006 Apr; 27(4):506-12. PubMed ID: 16539853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response by Pei et al. to letters regarding article, "Pharmacokinetic study of imrecoxib in patients with renal insufficiency".
    Pei Q; Xie JL; Zhang H; Yang GP
    Eur J Clin Pharmacol; 2020 Mar; 76(3):473-474. PubMed ID: 31897531
    [No Abstract]   [Full Text] [Related]  

  • 16. The Efficacy of Imrecoxib and Celecoxib in Axial Spondyloarthritis and Their Influence on Serum Dickopff-Related Protein 1 (DKK-1) Levels.
    Gao GM; Li YM; Zheng XL; Jiang DB; Zhang LL; Xu PH; Liu SY; Zheng ZH; Kan QC
    Med Sci Monit; 2017 Jun; 23():2985-2992. PubMed ID: 28626213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect of imrecoxib combined with lobaplatin on tumor growth and lymph node metastasis of human lung cancer xenografts in nude mice].
    Wang DC; Wang LC; Wang LJ; Chen G; Zhao YX; Zhao ZF; Li YH
    Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):340-5. PubMed ID: 27188605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB; Johnson RD; Jensen B; Magner D; Marbury T; Talbot GH
    Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and safety of darapladib in subjects with severe renal impairment.
    Magee MH; Shaddinger B; Collins D; Siddiqi S; Soffer J
    Br J Clin Pharmacol; 2015 Oct; 80(4):654-61. PubMed ID: 25953363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data.
    Yoshizawa K; Ikawa K; Ikeda K; Kumon H; Ohge H; Morikawa N
    Int J Antimicrob Agents; 2012 Nov; 40(5):427-33. PubMed ID: 22877766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.